Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regencell Bioscience Holdings Limited - Ordinary Shares (NQ:RGC)

5.420 -0.730 (-11.87%)
Delayed Quote Updated: 4:00 PM EST, Nov 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 276,123
Open 6.260
Bid (Size) 5.420 (200)
Ask (Size) 5.570 (600)
Prev. Close 6.150
Today's Range 5.310 - 6.510
52wk Range 4.510 - 69.00
Shares Outstanding 13,012,866
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are moving on Thursday? ↗
Via Chartmill
Top movers in Tuesday's pre-market session ↗
Via Chartmill

Performance

52-Week Range 92.1% below 52-week high
5.420
4.5152W Low 69.0052W High
1 Week 31.3% below 1-week high
5.311W Low 7.891W High

Regencell Bioscience Holdings Limited - Ordinary Shares (RGC) traded between $4.51 and $69.00 over the past 52 weeks and last traded at $5.42, 92.1% below its 52-week high. Over the past week it ranged between $5.31 and $7.89.

Past 12 Months
-25.4%
-25.1%
-10.4%
-80.1%
-73.6%
-60.0%
1W -$1.85
1M -$1.82
3M -$0.63
6M -$21.85
YTD -$15.12
1Y -$8.14

RGC was -60.0% over the past year, -80.1% over six months, -73.6% year to date, -25.4% in the last week.

12 Months vs Market
RGC
-60.0%
DIA
+12.6%
SPY
+12.2%
QQQ
+9.5%
IWM
+15.7%

Over the past 12 months RGC returned -60.0% versus DIA (Dow) +12.6%, SPY (S&P 500) +12.2%, QQQ (Nasdaq 100) +9.5% and IWM (Russell 2000) +15.7%.

Volume & Liquidity 1.13× 3-mo avg
Today 276,123 3-mo avg 244.3K
1W
158.0K
1M
386.7K
3M
244.3K
6M
265.9K
YTD
295.1K
1Y
285.3K

RGC most recently traded 276,123 shares against a 3-month average daily volume of 244.3K.

More News

Read More
Unusual volume stocks are being observed in Monday's session. ↗
Via Chartmill
Which stocks are moving on Wednesday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Via Chartmill
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC
From Pomerantz LLP
Via GlobeNewswire
News headline image
Regencell Deadline Today: Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
RGC FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
REGENCELL DEADLINE JUNE 23rd: Bragar Eagel & Squire, P.C. Urgently Reminds Regencell Bioscience Holdings Limited Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Deadline Soon: Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
RGC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
REGENCELL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
REGENCELL DEADLINE TUESDAY JUNE 23rd: Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited (NASDAQ:RGC) Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
From Pomerantz LLP
Via GlobeNewswire
News headline image
RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited (NASDAQ:RGC) Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
REGENCELL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100Kto Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC
From Pomerantz LLP
Via GlobeNewswire
News headline image
REGENCELL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
From Pomerantz LLP
Via GlobeNewswire
News headline image
RGC Shareholder Alert: Regencell Bioscience Holdings Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited and Encourages Investors to Contact the Firm Before June 23rd
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is Regencell Bioscience Holdings Limited - Ordinary Shares publicly traded?
Yes, Regencell Bioscience Holdings Limited - Ordinary Shares is publicly traded.
What exchange does Regencell Bioscience Holdings Limited - Ordinary Shares trade on?
Regencell Bioscience Holdings Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares?
The ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares is RGC on the Nasdaq Stock Market
What is the current price of Regencell Bioscience Holdings Limited - Ordinary Shares?
The current price of Regencell Bioscience Holdings Limited - Ordinary Shares is 5.420
When was Regencell Bioscience Holdings Limited - Ordinary Shares last traded?
The last trade of Regencell Bioscience Holdings Limited - Ordinary Shares was at 11/04/26 04:00 PM ET
What is the market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares?
The market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares is 70.53M
How many shares of Regencell Bioscience Holdings Limited - Ordinary Shares are outstanding?
Regencell Bioscience Holdings Limited - Ordinary Shares has 71M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.